NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT

Their core work

NNGYK is Hungary's National Centre for Public Health and Pharmacy — the country's central authority on public health surveillance, pharmaceutical regulation, and health protection. In H2020 projects, they contribute national-level epidemiological data, biomonitoring expertise, and regulatory knowledge across infectious diseases, chemical exposure, radiation protection, and food safety. Their role is that of a national reference laboratory and public health data provider, connecting Hungarian health surveillance systems to pan-European research networks.

What they specialise in

How they've shifted over time

In the early period (2015–2017), NNGYK focused on building foundational research infrastructure — establishing legal frameworks, operational procedures, and strategic research agendas for radiation protection (CONCERT) and high-pathogen research (ERINHA2), alongside chemical biomonitoring (HBM4EU). From 2019 onward, the focus shifted toward applied public health response: virus archiving for outbreak preparedness (EVA-GLOBAL), regulatory science capacity (STARS), and advancing pathogen infrastructure toward sustainability and service delivery (ERINHA-Advance). The trajectory moves clearly from planning and agenda-setting toward operational readiness and real-world health response capabilities.

NNGYK is moving from framework-building toward operational public health preparedness, making them increasingly relevant for pandemic response, regulatory harmonization, and health security consortia.

How they like to work

NNGYK participates exclusively as a consortium partner — never as coordinator — which is typical for national public health agencies contributing specialized national data and regulatory expertise to large European networks. Their 303 unique partners across 41 countries indicate they join very large, pan-European consortia (averaging 34 partners per project) rather than small focused teams. This makes them a reliable institutional partner that delivers national-level data contributions without seeking project leadership overhead.

With 303 unique consortium partners spanning 41 countries, NNGYK has one of the widest collaborative networks relative to its project count, reflecting its role as a national node in continent-wide public health and research infrastructure networks. Their reach extends well beyond the EU into associated countries.

What sets them apart

NNGYK is Hungary's national public health authority, which gives it something no university or private lab can offer: direct access to national health surveillance data, regulatory decision-making processes, and official biomonitoring programs. For any consortium needing a Hungarian national reference point for health data, chemical exposure monitoring, or pharmaceutical regulation, NNGYK is effectively the only option. Their dual competence in both public health surveillance and pharmaceutical regulation is unusual for a single institution.

Highlights from their portfolio

• CONCERT
  Largest project by funding (EUR 386K) — a European Joint Programme integrating radiation protection research across the continent.
• ERINHA-Advance
  Second-largest funding (EUR 258K) advancing infrastructure for highly pathogenic agents — directly relevant to pandemic preparedness.
• HBM4EU
  Flagship EU biomonitoring initiative establishing chemical exposure reference values for European populations — high policy impact.